作者: Uni Wong , Raymond K. Cross
DOI: 10.1007/978-3-319-60276-9_14
关键词: Anti-TNF therapy 、 Injection site reaction 、 Gastroenterology 、 Injection site 、 Medicine 、 Heart failure 、 Inflammatory bowel disease 、 Moderate to severe 、 Pathophysiology 、 Discontinuation 、 Internal medicine
摘要: Anti-TNF therapies are commonly used in the treatment of moderate to severe inflammatory bowel disease. The noninfectious and nonmalignant complications anti-TNF therapy include infusion or injection site reactions, psoriasiform eczematous eruptions, lupus-like reaction, hepatotoxicity, demyelination, heart failure. Infusion/injection dermatologic reactions often can be managed with supportive care without discontinuation anti-TNF. Early recognition management these is important initiate if indicated, minimize symptoms, transition other necessary. This chapter focuses on clinical presentation, pathophysiology, diagnostic evaluation, therapy.